it means exactly that- yes Vision it’s in public domain but it’s unpublished in the sense that at present the trial results have been communicated in abstract form for Congress and via Novartis press release , not fully published in a journal - a non issue as I expect it will be.
of course they won’t sue, they’ll be preoccupied meeting a worldwide regulatory submission process. It’s simply a poor look for Nox to ride Novartis coat tails in this way, imo. Comes across as a bit desperate.
Hmmm... Lutetium arm of vision n= 550; Lupin n= 56. Ten fold sample size difference and the Nox crew claiming they’ve added further 4 months survival. Hmmm...
- Forums
- ASX - By Stock
- NOX
- Novartis Vision trial result
Novartis Vision trial result, page-19
Featured News
Add NOX (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
0.010(14.3%) |
Mkt cap ! $23.37M |
Open | High | Low | Value | Volume |
7.0¢ | 8.0¢ | 7.0¢ | $4.207K | 56.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 118527 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 118527 | 0.075 |
2 | 14000 | 0.067 |
1 | 141114 | 0.066 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 4999 | 1 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
0.092 | 5555 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online